Experimental Treatment Could be Useful in Numerous Rare and Deadly Cancers
source: pixabay.com

Experimental Treatment Could be Useful in Numerous Rare and Deadly Cancers

While novel treatments have been rapidly emerging onto the drug scene, new treatment options for pancreatic cancer have fallen behind. But now, according to OncLive’s interview with Dr. P.A. Philip,…

Continue Reading Experimental Treatment Could be Useful in Numerous Rare and Deadly Cancers
A Surgery To Treat Obesity Found to Significantly Lower Risk of Pancreatic Cancer
source: pixabay.com

A Surgery To Treat Obesity Found to Significantly Lower Risk of Pancreatic Cancer

According to EMJ, findings from an analysis spanning 20 years has found that weight loss surgery used to address obesity also significantly lowers a person's risk of developing pancreatic cancer.…

Continue Reading A Surgery To Treat Obesity Found to Significantly Lower Risk of Pancreatic Cancer
People with IBD are Concerned Their Medication Raises Their Risk of Coronavirus
source: pixabay.com

People with IBD are Concerned Their Medication Raises Their Risk of Coronavirus

As reported in EMJ Reviews, the world is on alert, being told to wash their hands and keep distance amidst the COVID-19 pandemic. However, patients with inflammatory bowel disease (IBD)…

Continue Reading People with IBD are Concerned Their Medication Raises Their Risk of Coronavirus
Patients Who Received CRISPR Gene Editing for Beta Thalassemia and Sickle Cell Disease Remain Pain Free
source: pixabay.com

Patients Who Received CRISPR Gene Editing for Beta Thalassemia and Sickle Cell Disease Remain Pain Free

  The initial CRISPR treatment for sickle cell disease was administered to Victoria Gray in July 2019. Victoria, a resident of Forest, Mississippi, was born with sickle cell and has…

Continue Reading Patients Who Received CRISPR Gene Editing for Beta Thalassemia and Sickle Cell Disease Remain Pain Free
Study Illuminates Link Between Hematuria Remission and Outcomes for Immunoglobulin A Nephropathy Patients
source: pixabay.com

Study Illuminates Link Between Hematuria Remission and Outcomes for Immunoglobulin A Nephropathy Patients

Immunoglobulin A nephropathy (IgAN) is a glomerular disease which can lead to kidney failure. Between 70 and 100 percent of all IgAN patients also are diagnosed with microscopic hematuria, but…

Continue Reading Study Illuminates Link Between Hematuria Remission and Outcomes for Immunoglobulin A Nephropathy Patients
Couple Adopts Child with Hemophilia
https://pixabay.com/en/family-sunset-beach-happiness-2611748/

Couple Adopts Child with Hemophilia

Monica and Josh Poynter have recently adopted a nine-year-old boy, Trey, from China. They felt a connection to the boy as he has hemophilia type A, the same rare bleeding…

Continue Reading Couple Adopts Child with Hemophilia
FDA Designations Granted to PRAX-222, PRAX-562 for Epileptic Encephalopathies
Source: Pixabay.com

FDA Designations Granted to PRAX-222, PRAX-562 for Epileptic Encephalopathies

According to a recent press release from biopharmaceutical company Praxis Precision Medicines ("Praxis"), two of the company's drug candidates received either Orphan Drug or Rare Pediatric Disease designations for rare…

Continue Reading FDA Designations Granted to PRAX-222, PRAX-562 for Epileptic Encephalopathies
Infusion of Yescarta Resulted in 44 Percent 4-year Overall Survival Rate in Large B-cell Lymphoma
source: pixabay.com

Infusion of Yescarta Resulted in 44 Percent 4-year Overall Survival Rate in Large B-cell Lymphoma

  A recent announcement by Gilead Company citing data from Kite Pharma, one of its premier companies, set out remarkable results from Kite’s Zuma-1 clinical trial. The findings confirmed that…

Continue Reading Infusion of Yescarta Resulted in 44 Percent 4-year Overall Survival Rate in Large B-cell Lymphoma
Emmaus Life Sciences Makes Drug For Sickle Cell Disease Free For Those That Can’t Pay
source: pixabay.com

Emmaus Life Sciences Makes Drug For Sickle Cell Disease Free For Those That Can’t Pay

As reported in PR NewsWire;  in an effort to help the entirety of the sickle cell disease community, Emmaus Life Sciences, Inc has announced a program that will provide their…

Continue Reading Emmaus Life Sciences Makes Drug For Sickle Cell Disease Free For Those That Can’t Pay